-Advertisement-
-Advertisement-
Thyroid Eye Disease
Some patients with TED need longer to respond to teprotumumab
Patients with thyroid eye disease (TED) treated with teprotumumab may need longer than 12 weeks to see a clinically significant response, according to a study. Approximately half of the patients treated with teprotumumab experience significant improvements in proptosis at 6 weeks, according to recent trials, with a small subgroup not...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
By rd360stg
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Videos
23 Dec, 2021
17 Dec, 2021
Quizzes
Polls
-Advertisement-
-Advertisement-

Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
info@ihmholdings.com
QUICK LINKS
© 2022 IHM. RD 360 is a trademark of International Healthcare Media, LLC. All rights Reserved